Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

By Barzilai Nir   Guo Hua   Mahoney Erin M.   Caporossi Suzanne   Golm Gregory T.   Langdon Ronald B.   Williams-Herman Debora   Kaufman Keith D.   Amatruda John M.   Goldstein Barry J.   Steinberg Helmut  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1049-1058

Informa Healthcare

Access to resources Recommend Favorite

Treatment of patients with diabetic peripheral neuropathic pain in China: a double‐blind randomised trial of duloxetine vs. placebo

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 9, 2015-09 ,pp. : 957-966

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study

By Zerbini C.   Ozturk Z. E.   Grifka J.   Maini M.   Nilganuwong S.   Morales R.   Hupli M.   Shivaprakash M.   Giezek H.    

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2037-2049

Informa Healthcare

Access to resources Recommend Favorite

Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study*

By Hale Martin   Upmalis David   Okamoto Akiko   Lange Claudia   Rauschkolb Christine  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1095-1104

Informa Healthcare

Access to resources Recommend Favorite

Double-blind evaluation of short-term analgesic efficacy of orally administered dexketoprofen trometamol and ketorolac in bone cancer pain

By Rodriguez M.J.   Contreras D.   Galvez R.   Castro A.   Camba M.A.   Busquets C.   Herrera J.  

Pain, Vol. 104, Iss. 1, 2003-07 ,pp. : 103-110

Elsevier

Access to resources Recommend Favorite